Author

Firas Mourtada

Thomas Jefferson UniversityORCID 0000-0002-4388-5334Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Amit M. MaityiD· 1 shared Anil K. SoodiD· 1 shared Ayden Berndt· 1 shared Esther NeediD· 1 shared Feng Guo· 1 shared Lydia J. WilsoniD· 1 shared Matthew Goff· 1 shared Neetu Singh· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Amit M. MaityORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FOLR1-targeted Actinium-225-based Alpha-particle Therapy Eliminates Ovarian Cancer

Neetu Singh, Esther Need, Ayden Berndt, Matthew Goff, Lydia J. Wilson, Firas Mourtada, Feng Guo, Tara Mastren, Taslim Ahmed Al-Hilal, Anil K. Sood, Amit M. Maity, Scott C. Miller, Satoshi Minoshima, Shreya Goel, Sixiang Shi

This study demonstrates that FOLR1-targeted Actinium-225 alpha-particle therapy effectively treats ovarian cancer with high tumor regression and survival rates while minimizing toxicity.

Science Advances · Jun 24, 2026Peer-reviewedBioengineering